Besides PET amyloid imaging, cerebrospinal fluid (CSF) pathophysiological markers, including Aβ1–42, total tau, and pTau, have also shown high specificity in confirming AD pathophysiology. The gene discussed is MAPT; the disease is Alzheimer disease.